The Central Government is committed to strengthening India’s pharmaceutical industry by fostering innovation, research and development (R&D), and global competitiveness, Union Commerce and Industry Minister Piyush Goyal said.
He emphasized that the government’s focus is on creating a robust ecosystem that supports pharmaceutical companies, encourages greater investment in research and innovation, and enables Indian firms to expand their footprint in international markets.
Goyal highlighted that India’s pharmaceutical industry has emerged as a key pillar of the country’s healthcare system and economic growth, while also playing a vital role in supplying affordable, high-quality medicines to patients around the world.
He noted that continued investment in advanced technologies, research, and innovation, coupled with stronger collaboration between industry, academia, and other stakeholders, will be critical to driving the sector’s long-term growth.
The minister added that the government remains committed to making India’s pharmaceutical industry more competitive, sustainable, and globally recognized, reinforcing the country’s position as a leading global hub for pharmaceutical manufacturing and innovation.
